Efficacy of prophylactic dexamethasone in reducing post-embolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis
Abstract Background and objectives Transcatheter arterial chemoembolization (TACE) is a fundamental treatment for unresectable hepatocellular carcinoma despite its tendency to induce postembolization syndrome (PES), which can negatively impact the quality of life and treatment outcomes of patients....
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Gastroenterology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12876-025-04169-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849763643366834176 |
|---|---|
| author | Rongli Li Zhen Huang Yun Liu Teng Li |
| author_facet | Rongli Li Zhen Huang Yun Liu Teng Li |
| author_sort | Rongli Li |
| collection | DOAJ |
| description | Abstract Background and objectives Transcatheter arterial chemoembolization (TACE) is a fundamental treatment for unresectable hepatocellular carcinoma despite its tendency to induce postembolization syndrome (PES), which can negatively impact the quality of life and treatment outcomes of patients. This study aimed to evaluate the efficacy of prophylactic dexamethasone in reducing PES following TACE. Methods A thorough search across major databases was conducted to identify studies investigating the prophylactic use of dexamethasone in preventing and reducing PES. Efficacy was evaluated via a meta-analysis utilizing a random-effects model to determine the risk ratio (RR) and 95% confidence intervals (CIs), focusing on PES symptoms, including abdominal pain, fever, nausea, and vomiting. Results Among 406 meticulously reviewed studies, 5, encompassing a patient cohort of 400 individuals, were included in the final analysis. The results revealed a significant reduction in the overall incidence of abdominal pain (RR = 0.61; 95% CI: 0.51–0.75; P < 0.001), fever (RR = 0.46; 95% CI: 0.35–0.60; P < 0.001), and nausea and vomiting (RR = 0.57; 95% CI: 0.43–0.76; P < 0.001) using dexamethasone prophylactically. Conclusion This meta-analysis suggested that the prophylactic administration of dexamethasone effectively prevents and reduces PES, significantly reducing the incidence of key symptoms, including abdominal pain, fever, nausea, and vomiting. |
| format | Article |
| id | doaj-art-276f65dc50f545c1a15ff7df53ee6492 |
| institution | DOAJ |
| issn | 1471-230X |
| language | English |
| publishDate | 2025-08-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Gastroenterology |
| spelling | doaj-art-276f65dc50f545c1a15ff7df53ee64922025-08-20T03:05:21ZengBMCBMC Gastroenterology1471-230X2025-08-0125111110.1186/s12876-025-04169-3Efficacy of prophylactic dexamethasone in reducing post-embolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysisRongli Li0Zhen Huang1Yun Liu2Teng Li3Department of Interventional Radiology, The People‘s Hospital of WeifangDepartment of Interventional Radiology, The People‘s Hospital of WeifangDepartment of Hematology, The People‘s Hospital of WeifangDepartment of Interventional Radiology, The People‘s Hospital of WeifangAbstract Background and objectives Transcatheter arterial chemoembolization (TACE) is a fundamental treatment for unresectable hepatocellular carcinoma despite its tendency to induce postembolization syndrome (PES), which can negatively impact the quality of life and treatment outcomes of patients. This study aimed to evaluate the efficacy of prophylactic dexamethasone in reducing PES following TACE. Methods A thorough search across major databases was conducted to identify studies investigating the prophylactic use of dexamethasone in preventing and reducing PES. Efficacy was evaluated via a meta-analysis utilizing a random-effects model to determine the risk ratio (RR) and 95% confidence intervals (CIs), focusing on PES symptoms, including abdominal pain, fever, nausea, and vomiting. Results Among 406 meticulously reviewed studies, 5, encompassing a patient cohort of 400 individuals, were included in the final analysis. The results revealed a significant reduction in the overall incidence of abdominal pain (RR = 0.61; 95% CI: 0.51–0.75; P < 0.001), fever (RR = 0.46; 95% CI: 0.35–0.60; P < 0.001), and nausea and vomiting (RR = 0.57; 95% CI: 0.43–0.76; P < 0.001) using dexamethasone prophylactically. Conclusion This meta-analysis suggested that the prophylactic administration of dexamethasone effectively prevents and reduces PES, significantly reducing the incidence of key symptoms, including abdominal pain, fever, nausea, and vomiting.https://doi.org/10.1186/s12876-025-04169-3Transcatheter arterial chemoembolizationHepatocellular carcinomaPostembolization syndromeDexamethasoneMeta-analysis |
| spellingShingle | Rongli Li Zhen Huang Yun Liu Teng Li Efficacy of prophylactic dexamethasone in reducing post-embolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis BMC Gastroenterology Transcatheter arterial chemoembolization Hepatocellular carcinoma Postembolization syndrome Dexamethasone Meta-analysis |
| title | Efficacy of prophylactic dexamethasone in reducing post-embolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis |
| title_full | Efficacy of prophylactic dexamethasone in reducing post-embolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis |
| title_fullStr | Efficacy of prophylactic dexamethasone in reducing post-embolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis |
| title_full_unstemmed | Efficacy of prophylactic dexamethasone in reducing post-embolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis |
| title_short | Efficacy of prophylactic dexamethasone in reducing post-embolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis |
| title_sort | efficacy of prophylactic dexamethasone in reducing post embolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma a systematic review and meta analysis |
| topic | Transcatheter arterial chemoembolization Hepatocellular carcinoma Postembolization syndrome Dexamethasone Meta-analysis |
| url | https://doi.org/10.1186/s12876-025-04169-3 |
| work_keys_str_mv | AT ronglili efficacyofprophylacticdexamethasoneinreducingpostembolizationsyndromefollowingtranscatheterarterialchemoembolizationforhepatocellularcarcinomaasystematicreviewandmetaanalysis AT zhenhuang efficacyofprophylacticdexamethasoneinreducingpostembolizationsyndromefollowingtranscatheterarterialchemoembolizationforhepatocellularcarcinomaasystematicreviewandmetaanalysis AT yunliu efficacyofprophylacticdexamethasoneinreducingpostembolizationsyndromefollowingtranscatheterarterialchemoembolizationforhepatocellularcarcinomaasystematicreviewandmetaanalysis AT tengli efficacyofprophylacticdexamethasoneinreducingpostembolizationsyndromefollowingtranscatheterarterialchemoembolizationforhepatocellularcarcinomaasystematicreviewandmetaanalysis |